MENU
VERV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Verve Therapeutics (VERV) Earnings Date & Reports

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines... Show more

A.I. Advisor
published Earnings

VERV is expected to report earnings to rise 90.54% to -66 cents per share on August 07

Verve Therapeutics VERV Stock Earnings Reports
Q2'25
Est.
$-0.67
Q1'25
Beat
by $0.30
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.09
The last earnings report on May 14 showed earnings per share of -34 cents, beating the estimate of -64 cents. With 300.62K shares outstanding, the current market capitalization sits at 390.45M.
View a ticker or compare two or three
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 617 603-0070
Employees
255
Web
https://www.vervetx.com